Search

Aims to characterize the direct and indirect burden of PMS to patients, caregivers, and US healthcare system

We interviewed Idoia Muñoz Lizán, General Manager of the Basque Health Cluster and Platinum Sponsor of BIOSPAIN 2025, to analyze the role of the Basque Country in the global biotechnology landscape.

Genomcore has received the Best Practice Recognition award in the Impact category for the European project PRECISEU, which promotes personalized medicine in Europe. The award was presented at Life

Biolan launches a disruptive, unique, digitized and sustainable technological solution to the fishing industry: biofish 7000 tma

Meet our new member ceiA3-Campus de Excelencia Internacional Agroalimentario. . We spoke with Lola de Toro, Directora -Gerente ceiA3.

We interview Gabriel Tallada, CEO of Net-Pharma Hub, Platinum Sponsor of BIOSPAIN 2025, who analyzes the key role that the collaborative economy plays in terms of innovation.

Almirall stands out at the EADV 2025 Congress with 44 scientific presentations and new data from its portfolio in atopic dermatitis, psoriasis, actinic keratosis, and hidradenitis suppurativa

Oryzon Genomics S.A., a clinical-stage biopharmaceutical company and European leader in epigenetics, has strengthened its global intellectual property position after receiving new patent grant

BCN HEALTH participated in the European Association for the Study of the Liver (EASL) International Liver Congress (ILC 2025), which took place in May in Amsterdam, the Netherlands. Two new

With more than 20 years of experience, the Spanish company develops automation and digital solutions that enhance patient safety, optimize pharmaceutical processes, and improve the efficiency of

Embryotools, a biotechnology centre based at the Parc Científic de Barcelona (PCB), has achieved a new milestone in the field of assisted reproduction with the birth of the world’s first foal

Immunobiogram® is a test that measures in vitro the sensitivity (response) of each patient's immune system cells to immunosuppressive drugs, with the aim of facilitating the personalization of

We interviewed Pedro Martínez Córdoba, Councillor for Economic Promotion of Salamanca City Council, Gold Sponsor of BIOSPAIN 2025, to analyze the Abioinnova initiative.

Viva In Vitro, an AseBio member, has developed VIVA-ELISA, a biotechnology tool that rapidly detects activation of the NLRP3 inflammasome, enabling evaluation of the immune system’s ability to respond

Growing investment in R&D, eliminating unnecessary bureaucratic hurdles, and creating governance structures of its own are the main actions the European Union will undertake to reinforce its

We interviewed Román Rodríguez González, Regional Minister of Education, Science, Universities and Vocational Training of the Xunta de Galicia, Gold Sponsor, to analyze the Xunta’s commitment to